APA (7th ed.) Citation

Hemberger, M. (2008). Verbesserung der vaskulären Dysfunktion bei Diabetes mellitus durch den HMG-CoA-Reduktase-Inhibitor Rosuvastatin: = Improved Vascular Function and Reduced Platelet Activation by Chronic HMG-CoA-Reductase Inhibition with Rosuvastatin in Rats with Streptozotocin-induced Diabetes Mellitus.

Chicago Style (17th ed.) Citation

Hemberger, Melinda. Verbesserung Der Vaskulären Dysfunktion Bei Diabetes Mellitus Durch Den HMG-CoA-Reduktase-Inhibitor Rosuvastatin: = Improved Vascular Function and Reduced Platelet Activation by Chronic HMG-CoA-Reductase Inhibition with Rosuvastatin in Rats with Streptozotocin-induced Diabetes Mellitus. 2008.

MLA (9th ed.) Citation

Hemberger, Melinda. Verbesserung Der Vaskulären Dysfunktion Bei Diabetes Mellitus Durch Den HMG-CoA-Reduktase-Inhibitor Rosuvastatin: = Improved Vascular Function and Reduced Platelet Activation by Chronic HMG-CoA-Reductase Inhibition with Rosuvastatin in Rats with Streptozotocin-induced Diabetes Mellitus. 2008.